Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 26254683

Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): long-term results of a randomised controlled trial.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Lancet Oncol
Publication date
2015 Sep
First author
Shapiro J

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet Oncol. 2015 Sep;16(9):1008-1009. doi: 10.1016/S1470-2045(15)00127-8.
    note
    Source null
    related pmid
    26254684
    relationship
    Comment in
  2. citation
    Nat Rev Gastroenterol Hepatol. 2015 Sep;12(9):489. doi: 10.1038/nrgastro.2015.145.
    note
    Source null
    related pmid
    26284564
    relationship
    Comment in
  3. citation
    Nat Rev Clin Oncol. 2015 Oct;12(10):561. doi: 10.1038/nrclinonc.2015.143.
    note
    Source null
    related pmid
    26323389
    relationship
    Comment in
  4. citation
    Chirurg. 2016 Apr;87(4):345. doi: 10.1007/s00104-016-0176-3.
    note
    Source null
    related pmid
    27059929
    relationship
    Comment in

Authors and identifiers

  1. name
    Shapiro J
    type
    Author
  2. name
    van Lanschot JJB
    type
    Author
  3. name
    Hulshof MCCM
    type
    Author
  4. name
    van Hagen P
    type
    Author
  5. name
    van Berge Henegouwen MI
    type
    Author
  6. name
    Wijnhoven BPL
    type
    Author
  7. name
    van Laarhoven HWM
    type
    Author
  8. name
    Nieuwenhuijzen GAP
    type
    Author
  9. name
    Hospers GAP
    type
    Author
  10. name
    Bonenkamp JJ
    type
    Author
  11. name
    Cuesta MA
    type
    Author
  12. name
    Blaisse RJB
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Shapiro J
    type
    Author
  2. name
    van Lanschot JJB
    type
    Author
  3. name
    Hulshof MCCM
    type
    Author
  4. name
    van Hagen P
    type
    Author
  5. name
    van Berge Henegouwen MI
    type
    Author
  6. name
    Wijnhoven BPL
    type
    Author
  7. name
    van Laarhoven HWM
    type
    Author
  8. name
    Nieuwenhuijzen GAP
    type
    Author
  9. name
    Hospers GAP
    type
    Author
  10. name
    Bonenkamp JJ
    type
    Author
  11. name
    Cuesta MA
    type
    Author
  12. name
    Blaisse RJB
    type
    Author
bibliography ids
  1. nci-bib-758e65e8bbaadd5677481a33
book metadata
content sha256
0010ec273cc5f4cace84b4691509413af5b48ae6acb9e650b175bf015a41ea13
document type
citation
dois
  1. 10.1016/S1470-2045(15)00040-6
electronic publication date
display
2015 Aug 5
precision
day
year
2015
evidence scope
bibliographic_metadata_only
id
pubmed:26254683
immutable id
pubmed:26254683@0010ec273cc5f4cace84b4691509413af5b48ae6acb9e650b175bf015a41ea13
journal
abbreviation
Lancet Oncol
issn electronic
1474-5488
issn print
1470-2045
issue
9
name
The Lancet. Oncology
nlm unique id
100957246
pages
1090-1098
volume
16
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet Oncol. 2015 Sep;16(9):1008-1009. doi: 10.1016/S1470-2045(15)00127-8.
    note
    Source null
    related pmid
    26254684
    relationship
    Comment in
  2. citation
    Nat Rev Gastroenterol Hepatol. 2015 Sep;12(9):489. doi: 10.1038/nrgastro.2015.145.
    note
    Source null
    related pmid
    26284564
    relationship
    Comment in
  3. citation
    Nat Rev Clin Oncol. 2015 Oct;12(10):561. doi: 10.1038/nrclinonc.2015.143.
    note
    Source null
    related pmid
    26323389
    relationship
    Comment in
  4. citation
    Chirurg. 2016 Apr;87(4):345. doi: 10.1007/s00104-016-0176-3.
    note
    Source null
    related pmid
    27059929
    relationship
    Comment in
outcomes validated
false
pmid
26254683
provenance
batch id
4c1ece5bfc3d8e2be622
provider
NCBI PubMed ESummary
record sha256
bcdc1089ef43274f7a5ed3527d747889e1a357aac9e05588b4ed6a916a97c613
response sha256
85f81bf7b60c457e4b5806b47c7c67c745ada2ae114069aa45de5ef977770dba
retrieved at
2026-09-09T23:47:12.730551+00:00
publication date
display
2015 Sep
precision
month
year
2015
publication types
  1. Journal Article
  2. Randomized Controlled Trial
  3. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/26254683/
title
Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): long-term results of a randomised controlled trial.

Preserved source evidence · Not medical advice